SYK.NYSEStryker CORP

Form 4: Stryker Corp Executive M Kathryn Fink Reports Acquisition of Shares

Sentiment:

SEC Form 4 Filing


M Kathryn Fink, VP and Chief HR Officer of Stryker Corp, reports acquiring 4,189 shares of common stock due to the achievement of performance goals.

Summary

  • M Kathryn Fink, VP, Chief HR Officer of Stryker Corp, filed a Form 4 indicating changes in beneficial ownership.
  • On March 10, 2025, Fink acquired 4,189 shares of Stryker common stock.
  • These shares were acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals.
  • The acquired shares vest on March 21, 2025.
  • Fink also owns 14,055 shares of common stock directly, including 127 shares acquired through the Employee Stock Purchase Plan (ESPP) as of December 31, 2024.
  • Additionally, Fink indirectly owns 400 shares through a 401K and 177 shares through the 2023 Mary Fink Living Trust, which includes shares previously owned directly and transferred on December 9, 2024.

Sentiment

Score: 7

Explanation: The document indicates positive performance leading to stock acquisition, suggesting a favorable outlook. However, it's a routine filing, so the impact is moderate.

Positives

  • The acquisition of shares by a company executive based on performance goals suggests confidence in the company's future performance.
  • The executive's participation in the Employee Stock Purchase Plan (ESPP) indicates a commitment to the company's long-term success.

Future Outlook

The vesting of the acquired shares on March 21, 2025, is a future event.

Industry Context

Executive stock ownership is a common practice in the healthcare industry to align management's interests with those of shareholders.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units that vest over time based on performance metrics.
  • Comparing M Kathryn Fink's stock ownership and acquisition terms with those of executives at similar medical device companies like Medtronic or Johnson & Johnson would provide a benchmark for assessing the competitiveness of Stryker's executive compensation.

Stakeholder Impact

  • The stock acquisition could positively impact shareholder confidence.
  • The achievement of performance goals may lead to increased employee morale.

Key Dates

DateDescription
December 9, 2024177 shares previously owned directly were transferred to the Living Trust
December 31, 2024Date of the latest available statement of the reporting person's ESPP holdings
March 10, 2025Transaction date of stock acquisition
March 21, 2025Vesting date of the acquired shares
March 12, 2025Date of signature

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.